Effects of Felodipine ER, a Dihydropyridine Calcium Antagonist, on Blood Pressure and Serum Lipids

References

• Assmann G., Scheftler G. Diagnostik und Therapie der Hyperlipidämien. Dtsch. Ärtzebl. 1988; 85: C13241. Assmann G., Scheftler G. Diagnostik und Therapie der Hyperlipidämien. Dtsch. Ärtzebl. 1988; 85: C1324
   Google Scholar
• Baggio E., Maraffi F., Montalto C., Conti D., Ravera E., Ottolini S., Gandini R. The effects of felodipine and amlodipine on glucose and lipid metabolism in patients affected by non-insulin-dependent diabetes mellitus and hypertension. A comparative, randomized, parallel-group study. Curr. Ther. Res. 1995; 56: 1050, 10582. Baggio E., Maraffi F., Montalto C., Conti D., Ravera E., Ottolini S., Gandini R. The effects of felodipine and amlodipine on glucose and lipid metabolism in patients affected by non-insulin-dependent diabetes mellitus and hypertension. A comparative, randomized, parallel-group study. Curr. Ther. Res. 1995; 56: 1050, 1058
   Web of Science ®Google Scholar
• Becker R. H. A., Linz W., Wiemer G., Nordlander M. Low-dose felodipine treatment attenuates endothelial dysfunction in rabbits fed an atherogenic diet. J. Cardiovasc. Pharmacol. 1991; 18: S36–S41, Suppl 103. Becker R. H. A., Linz W., Wiemer G., Nordlander M. Low-dose felodipine treatment attenuates endothelial dysfunction in rabbits fed an atherogenic diet. J. Cardiovasc. Pharmacol. 1991; 18: S36–S41, Suppl 10
   PubMed Web of Science ®Google Scholar
• Blychert E. Felodipine pharmacokinetics and plasma concentration vs effect relationships. Blood Press. 1992; 1–30, Suppl 24. Blychert E. Felodipine pharmacokinetics and plasma concentration vs effect relationships. Blood Press. 1992; 1–30, Suppl 2
   Google Scholar
• Büning H., Trenkler G. Nichtparametrische statistische Methoden. de Gruyter, Berlin 19785. Büning H., Trenkler G. Nichtparametrische statistische Methoden. de Gruyter, Berlin 1978
   Google Scholar
• Clement D. L., De Pue N. Y. Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients. Drugs 1985; 29: 137–143, Suppl 26. Clement D. L., De Pue N. Y. Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients. Drugs 1985; 29: 137–143, Suppl 2
   PubMed Web of Science ®Google Scholar
• DeQuattro V. Efficacy and safety of felodipine, a new dihydropyridine calcium channel blocker, in elderly hypertensive patients. Clin. Exp. Hypertens. 1992; A14: 965–9887. DeQuattro V. Efficacy and safety of felodipine, a new dihydropyridine calcium channel blocker, in elderly hypertensive patients. Clin. Exp. Hypertens. 1992; A14: 965–988
   Google Scholar
• DiBona G.R., Sawin L. L. Renal tubular site of action of felodipine. J. Pharmacol. Exp. Ther. 1984; 228: 420, 4288. DiBona G.R., Sawin L. L. Renal tubular site of action of felodipine. J. Pharmacol. Exp. Ther. 1984; 228: 420, 428
   PubMed Web of Science ®Google Scholar
• Edgar B., Bengtsson B., Elmfeldt D., Lundborg P., Nyberg G., Raner S., Rönn O. Acute diuretic/natriuretic properties of felodipine in man. Drugs 1985; 29: 176–184, Suppl 29. Edgar B., Bengtsson B., Elmfeldt D., Lundborg P., Nyberg G., Raner S., Rönn O. Acute diuretic/natriuretic properties of felodipine in man. Drugs 1985; 29: 176–184, Suppl 2
   PubMed Web of Science ®Google Scholar
• Hedner T., Elmfeldt D., Dahlöf C., Sjögren E. Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension. Drugs 1987; 34: 125–131, Suppl 310. Hedner T., Elmfeldt D., Dahlöf C., Sjögren E. Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension. Drugs 1987; 34: 125–131, Suppl 3
   PubMed Web of Science ®Google Scholar
• Herlitz H., Aurell M., Conradson T. Felodipine, an arteriolar dilator with pronounced antihypertensive effect. Lancet 1983; 1: 409, 41011. Herlitz H., Aurell M., Conradson T. Felodipine, an arteriolar dilator with pronounced antihypertensive effect. Lancet 1983; 1: 409, 410
   PubMed Web of Science ®Google Scholar
• Lassen E., Ahlstrom F., Bogeskov-Jensen I., Frimodt-Moller J., Rishoj Nielsen M., Wickers-Nielsen N., Winkel O. A comparison of felodipine and nitrendipine in the treatment of hypertension. J. Cardiovasc. Pharmacol. 1990; 15: S94, Suppl 412. Lassen E., Ahlstrom F., Bogeskov-Jensen I., Frimodt-Moller J., Rishoj Nielsen M., Wickers-Nielsen N., Winkel O. A comparison of felodipine and nitrendipine in the treatment of hypertension. J. Cardiovasc. Pharmacol. 1990; 15: S94, Suppl 4
   PubMed Web of Science ®Google Scholar
• Ljung B. Vascular selectivity of felodipine. Drugs 1985; 29: 46–58, Suppl 213. Ljung B. Vascular selectivity of felodipine. Drugs 1985; 29: 46–58, Suppl 2
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br. Med. J. 1985; 291: 97, 10414. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br. Med. J. 1985; 291: 97, 104
   PubMed Web of Science ®Google Scholar
• Nielsen M. R., Winkel O. P., Ahlstrom F., Frimodt-Moller J., Bogeskov-Jensen I., Wickers-Nielsen N., Lassen E. Effects on plasma lipids during long term antihypertensive treatment with felodipine. Drug Invest. 1992; 4: 361, 36415. Nielsen M. R., Winkel O. P., Ahlstrom F., Frimodt-Moller J., Bogeskov-Jensen I., Wickers-Nielsen N., Lassen E. Effects on plasma lipids during long term antihypertensive treatment with felodipine. Drug Invest. 1992; 4: 361, 364
   Google Scholar
• Nilsson-Ehle, P., The Swedish MC study group. Felodipine does not affect plasma lipoprotein concentrations. J. Cardiovasc. Pharmacol. 1990; 15: S1, 12, Suppl 416. Nilsson-Ehle, P., The Swedish MC study group. Felodipine does not affect plasma lipoprotein concentrations. J. Cardiovasc. Pharmacol. 1990; 15: S1, 12, Suppl 4
   PubMedGoogle Scholar
• Nilsson-Ehle P. Felodipine does not affect plasma lipoprotein concentrations. J. Cardiovasc. Pharmacol. 1988; 12: S183, Suppl 617. Nilsson-Ehle P. Felodipine does not affect plasma lipoprotein concentrations. J. Cardiovasc. Pharmacol. 1988; 12: S183, Suppl 6
   Google Scholar
• Pocock S. J. Clinical Trials: A Practical Approach. Wiley, New York 199118. Pocock S. J. Clinical Trials: A Practical Approach. Wiley, New York 1991
   Google Scholar
• Sachs L. Angewandte Statistik. 5th edn. Springer-Verlag, Berlin 197819. Sachs L. Angewandte Statistik. 5th edn. Springer-Verlag, Berlin 1978
   Google Scholar
• Schersten B. F. E. Unchanged lipid and lipoprotein concentrations in hypertensive patients with type II diabetes mellitus during one year of treatment with felodipine and nifedipine compared with placebo. Am. J. Hypertens. 1994; 7: 73A20. Schersten B. F. E. Unchanged lipid and lipoprotein concentrations in hypertensive patients with type II diabetes mellitus during one year of treatment with felodipine and nifedipine compared with placebo. Am. J. Hypertens. 1994; 7: 73A
   Google Scholar
• Schneider J. Serum lipoproteins in hyperlipoproteinemic patients with essential hypertension treated with felodipine for two years. Curr. Ther. Res. 1991; 50: 118, 12621. Schneider J. Serum lipoproteins in hyperlipoproteinemic patients with essential hypertension treated with felodipine for two years. Curr. Ther. Res. 1991; 50: 118, 126
   Web of Science ®Google Scholar
• Shionoiri H., Takizawa T., Ohyama Y., Ishii J., Katayama S., Nagasawa T., Kitamoto K., Nagasawa K., Hariya Y., Sato R., Ito T., Ishii M. Felodipine therapy may not alter glucose and lipid metabolism in hypertensives. Hypertension 1994; 23: 1215–1219, Felodipine Multicenter Prospective Study Group in Japan Suppl I22. Shionoiri H., Takizawa T., Ohyama Y., Ishii J., Katayama S., Nagasawa T., Kitamoto K., Nagasawa K., Hariya Y., Sato R., Ito T., Ishii M. Felodipine therapy may not alter glucose and lipid metabolism in hypertensives. Hypertension 1994; 23: 1215–1219, Felodipine Multicenter Prospective Study Group in Japan Suppl I
   Google Scholar